Psychobiologic correlates of treatment response in schizophrenia

Neuropsychopharmacology

Volumn 14, Issue , 1996, Pages 13S-21S

  Lieberman, Jeffrey A ^a   Ma Alvir, Jose ^a   Koreen, Amy ^a   Geister, Steven ^a   Chakos, Miranda ^a   Sheitman, Brian ^a   Woerner, Margaret ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antipsychotic Drugs; Brain morphology; Deterioration; Dopamine; Outcome; Schizophrenia

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HOMOVANILLIC ACID;

ADULT; BRAIN CORTEX; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBIOLOGY; NEUROPATHOLOGY; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA;

FOLLOW-UP STUDIES; HUMANS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0029993441     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00200-W     Document Type: Article

References (35)

1. Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M, Alvir JMJ, Snyder PJ, Lieberman JA (1994): Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 151(10):1437-1447
2. Carpenter WT, Buchanan RW (1989): Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia. In Schultz SC, Tamminga CT (eds), Schizophrenia: Scientific Progress. New York, Oxford Press
3. Carpenter WT, Heinrichs DW, Wagman AMI (1988): Deficit and non-deficit forms of schizophrenia: The concept. Am J Psychiatry 145:578-583
4. Chakos MH, Lieberman JA, Bilder RM, Lerner G, Bogerts B, Degreef G, Wu H, Ashtari M (1994): Increase in caudate nuclei volumes of first episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151(10): 1430-1436
5. Chakos MH, Mayerhoff DI, Loebel AD, Alvir JM, Lieberman JA (1992): Incidence and correlates of acute extrapyra- midal symptoms in first-episode schizophrenia. Psy- chopharmacol Bull 28(1) 81-86
6. Crow TJ, DeLisi LE, Johnstone EC (1990): In reply A locus closer to the telomere? Br J Psychiatry 156:416-420
7. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC (1986): A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 428:120-127
8. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir J, Ma J, Lieberman JA (1992): Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 49:531-537
9. Degreef G, Ashtari M, Wu H, Borenstein M, Geisler S, Lieberman J (1991): Follow-up MRI study in first episode schizophrenia. Schizophr Res 5:204-206
10. Haug OJ (1962): Pneumoencephalographic studies in mental disease. Acta Psychiatry Scand 165(suppl): 1-114
11. Huber G (1957): Pneumoencephalographische und psychopathologische Bilder bei endogen Psychosen. Springer, Berlin.
12. Illowsky BP, Juliano AM, Bigelow LB, Weinberger DR (1988): Stability of CT scan findings in schizophrenia: Results of an eight-year follow-up study. J Neurol Neurosurg Psychiatry 51:209-213
13. Koreen A, Lieberman J, Alvir J, Chakos M, Loebel A, Cooper T, Kane J (1994a): Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first episode schizophrenic patients. Am f Psychiatry 151:35-39
14. Koreen AM, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T (1994b): Plasma homovan- illic acid in first episode schizophrenia: Psychopathology and treatment response. Arch Gen Psychiatry 51:132-138
15. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J (1993): Depression in first episode schizophrenia. Am J Psychiatry 150:1643-1648
16. Lieberman JA, Alvir JMJ, Woerner M, Degreef G, Bilder R, Ashtari M, Bogerts B, Mayerhoff DI, Loebel A, Levy D, Hinrichsen G, Szymanski S, Chakos M, Borenstein M, Kane JM (1992a): Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital: Design, methodology and summary of findings. Schizophr Bull 18(3):351-371
17. Lieberman J, Bogerts B, Degreef G, Ashtari M, Alvir J (1992b): Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 149(6):784-794
18. Lieberman JA, Jody D, Alvir JMJ, Ashtari M, Levy D, Bogerts B, Degreef G, Mayerhoff D, Cooper T (1993a): Brain morphology, dopamine, and eye tracking abnormalities in first episode schizophrenia: Prevalence and clinical correlates. Arch Gen Psychiatry 50:357-368
19. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M (1993b): Time course and biological correlates of treatment response in first episode schizophrenia. Arch Gen Psychiatry 50:369-376
20. Lieberman JA, Kinon BJ, Loebel AD (1990): Dopaminergic mechanisms of idiopathic and drug-induced psychosis. Schizophr Bull 16(1):97-110
21. Lieberman JA, Koreen A (1993): Neurochemistry and neuroendocrinology of schizophrenia. A selective review. Schizophr Bull 19(2):371-429
22. Lieberman JA, Sobel S (1993): Predictors of treatment response and course of schizophrenia. Curr Opin Psychiatry 6:63-69
23. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR (1992): Duration of psychosis and outcome in first episode schizophrenia. Am J Psychiatry 149:1183-1188
24. May PR, Tuma AH, Dixon WJ (1981): Schizophrenia: A follow-up study of the results of the five forms of treatment. Arch Gen Psychiatry 38:776-784
25. Mayerhoff DI, Loebel AD, Borenstein M, Szymanski SR, Geisler SH, Alvir JMJ, Lieberman JA (1994): The deficit state in first-episode schizophrenia. Am J Psychiatry 151(10):1417-1422
26. McGlashan TH (1988): A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 14(4):515-542
27. McGlashan TH, Fenton WS (1991): Classical subtypes for schizophrenia: Literature review for DSM-IV. Schizophr Bull 17:609-632
28. Murray RM, Lewis SW (1987): Is schizophrenia a neurode- velopmental disorder? Br Med J 295:681-682
29. Post RM (1992): Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010
30. Post RM, Weiss SRB (1992): Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic. Biol Psychiatry 32:469-484
31. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, Woerner M, Cooper T (1995): Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 152:698-703
32. Waddington JL, Lieberman JA (1994): New insights into clinical issues in schizophrenia. Psychopharmacol 8:65-66
33. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
34. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG, McSparren J (1990): Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 27:341-352
35. Wyatt RJ (1991): Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17:325-351